Cite

HARVARD Citation

    Ungar, B. et al. (2023). The impact of dupilumab treatment on SARS‐CoV‐2 T cell responses in atopic dermatitis patients. Allergy. 78 (2), pp. 571-574. [Online]. 
  
Back to record